Category Archives: Government Affairs

Want To Move Forward Faster? Activate The Collaborative Gene

clip_image002Arizona biosciences sector demonstrates how to accelerate innovation and job growth and offers insight on how Washington can keep things moving forward faster by activating its “collaborative gene.”

These days tales of economic vitality are few and far between making Arizona’s bioscience sector an inspiration to all as the nation focuses on jobs and economic recovery. Continue reading

Study: Medical Device Tax Could Cost Jobs, Stifle Innovation

WASHINGTON,D.C. –The medical device tax, if implemented, could cost tens of thousands of jobs, almost double the industry’s total taxes, raise the effective tax rate to among the highest in the world, and harm U.S. competiveness, according to a study released today by the Advanced Medical Technology Association (AdvaMed).  The new study, “Employment Effects of the New Excise Tax on the Medical Device Industry,” by Manhattan Institute senior fellow Diana Furchtgott-Roth and Hudson Institute senior fellow Harold Furchtgott-Roth, outlines a number of economic harms likely to result from the tax. Continue reading

The Latest from the Capitols – 09 06 2011

AZBio uses StateNet from Lexis Nexis to stay up to date on  what is happening on Capitol Hill and across the 50 states.    To get the latest news, delivered to your email mailbox, get your complimentary subscription at StateNet.com or read the copy on-line here. Continue reading

Tips on Writing Powerful Public Comment Letters Regarding Proposed Regulations

By: Michael T. Hull – Managing Director, InVent Life Sciences   mhull@inventls.com  (Former Regional Advocate for the U.S. SBA Office of Advocacy)

The federal government proposes and finalizes approximately 4,000 new rules every year. In general approximately 800-1,000 will directly affect small business. A 2008 study by the U.S. Small Business Administration’s Office of Advocacy estimated that the cost of complying with federal rules and regulations exceeds $1.75 trillion per year with small businesses spending approximately 36% more per employee than their large business counterparts. Continue reading

The FDA When There’s An App For That

There is a lot happening on the medical device front these days around MDDS (Medical Device Data Systems) and the FDA is paying close attention with new regulations, guidance and requests for comment. 

With the  April 2012 compliance deadline less than 8 months away, AZBio Member John C. Hoffman of QMR is paying close attention too and keeping our community in the loop via the AZBio  Resource Network Group on LinkedIn.  If you and your team are working in the MDDS space, you’ll want to get connected and join the discussion.

Continue reading

The Latest from the Capitol – 08 15 2011

AZBio uses StateNet from Lexis Nexis to stay up to date on  what is happening on Capitol Hill and across the 50 states.    To get the latest news, delivered to your email mailbox, get your complimentary subscription at StateNet.com or read the copy on-line here. Continue reading

The Latest from the Capitol 08 08 2011

AZBio uses StateNet from Lexis Nexis to stay up to date on  what is happening on Capitol Hill and across the 50 states.    To get the latest news, delivered to your email mailbox, get your complimentary subscription at StateNet.com or read the copy on-line here. Continue reading

Guest Post: 3 Steps to Reclaim Our Spot as Global Innovation Leader

Guest Post by Zane Safrit as originally posted at www.MyVenturePad.com and www.ZaneSafrit.com

Zane Safrit

July 04, 2011

President Obama: 3 Steps to Reclaim Our Spot as Global Innovation Leader

Continue reading

Advocacy groups launch IPAB watch

AZBIO Washington Watch

uscapSeveral minority organizations and disease advocacy groups are starting a website to track concerns about and opposition to the Independent Payment Advisory Board. Continue reading

BIO Unveils Strategic Initiative to Speed Scientific Breakthroughs, Develop Cures and Grow the Bio-Economy

BIO2011 in Washington DC“Unleashing the Promise of Biotechnology: Advancing American Innovation to Cure Disease and Save Lives” Provides Roadmap for Transformative Policy Changes


WASHINGTON, D.C. (Wednesday, June 29, 2011) – The Biotechnology Industry Organization (BIO) released today a summary of legislative proposals to reform the investment and regulatory environment for biotech innovation. These proposals are designed to unleash the innovation required to cure disease and make the U.S. healthcare system more affordable, efficient, and of higher quality, as well as to foster the development of breakthrough technologies to provide alternative energy sources, combat hunger and protect against bio-terrorism. The policy proposals, released at a press briefing at the 2011 BIO International Convention held here this week, will serve as the organization’s targeted advocacy plan in these two areas.

Continue reading